The analysis was truncated. Let me walk you through every detail of the poster from the content I generated and the full medical knowledge behind it.
Electrolyte Disorders - Clinical Reference Card: Full Detail
HOW THE POSTER IS STRUCTURED
The poster has 4 color-coded columns (one per disorder) and 6 rows of content:
| Row | Content |
|---|
| 1 | Header: Name + Definition + Normal Range |
| 2 | Primary Defect / Mechanism |
| 3 | Causes (bulleted) |
| 4 | Clinical Features / Symptoms |
| 5 | ECG Changes |
| 6 | Treatment (Emergency + Chronic) |
| Bottom | Summary Comparison Table |
COLUMN 1 - HYPONATREMIA (Blue)
Header
- Serum Na+ < 135 mmol/L
- Normal: 135-145 mmol/L
- Most common electrolyte disorder in hospitalized patients (15-30%)
Primary Defect
Water excess relative to sodium OR sodium loss exceeding water loss. Result: low plasma osmolality → water shifts INTO brain cells → cerebral edema.
Causes
Step 1 - Check plasma osmolality:
- Normal osmolality (280-295) → Pseudohyponatremia: hyperlipidemia, hyperproteinemia
- High osmolality → Hyperosmolar: hyperglycemia (every 100 mg/dL glucose rise drops Na+ by ~1.6 mmol/L), mannitol, uremia
- Low osmolality → True hypoosmotic hyponatremia (most common - proceed to Step 2)
Step 2 - Check volume status + urine Na+:
| Volume | Urine Na+ | Causes |
|---|
| Hypovolemic | <10 | Vomiting, diarrhea, burns, sweating, third-spacing |
| Hypovolemic | >20 | Diuretics, Addison's, RTA, salt-losing nephropathy |
| Euvolemic | High (>20) | SIADH, hypothyroidism, hypoadrenalism |
| Hypervolemic | <10 | CHF, cirrhosis, nephrotic syndrome |
| Hypervolemic | >20 | Acute/chronic renal failure |
SIADH causes (very common exam topic):
- CNS: meningitis, encephalitis, stroke, SAH, head trauma
- Pulmonary: pneumonia, TB, COPD, abscess, positive pressure ventilation
- Drugs: SSRIs, carbamazepine, cyclophosphamide, vincristine, chlorpropamide, NSAIDs, opioids
- Malignancy: small cell lung cancer (most common), pancreatic ca, duodenal ca
- Post-surgery (pain/stress → ADH release)
Clinical Features
| Na+ Level | Symptoms |
|---|
| 130-135 | Often asymptomatic; nausea, malaise |
| 125-130 | Headache, lethargy, confusion |
| 120-125 | Disorientation, behavioral change |
| <120 | Seizures, stupor, coma |
| <105 | Brain herniation, death |
- Acute drops (within 24-48 hrs) cause symptoms at higher Na+ levels (~125)
- Chronic drops are better tolerated (brain has adapted)
ECG Changes
- No specific ECG pattern for hyponatremia itself
- Note: underlying cause (e.g., Addison's with hyperkalemia) may produce ECG changes
Treatment
Acute symptomatic (seizures/herniation):
- 100 mL of 3% NaCl IV over 10 minutes - repeat up to 3 times
- Target: raise Na+ by 4-6 mmol/L urgently to stop symptoms
- No restriction on rate if truly acute hyponatremia (<24-48 hrs)
Chronic hyponatremia:
- Maximum correction: 6-8 mmol/L per 24 hours (absolute max 10-12 mmol/L/day)
- SIADH: fluid restriction 500-1000 mL/day; salt tablets; furosemide + NaCl
- Vaptans (tolvaptan, conivaptan): V2 receptor antagonists - for euvolemic/hypervolemic SIADH
- Treat underlying cause
⚠️ Osmotic Demyelination Syndrome (ODS / Central Pontine Myelinolysis):
- Caused by overcorrection of chronic hyponatremia
- Risk: Na+ <105 for >48 hrs, hypokalemia, alcohol, malnutrition, liver disease
- Features: locked-in syndrome, pseudobulbar palsy, quadriplegia, ataxia
- MRI: T2 hyperintensity in pons and extrapontine areas
- Prevention: NEVER exceed 10-12 mmol/L/24 hrs
- If overcorrection occurs: re-lower Na+ with hypotonic saline + desmopressin
COLUMN 2 - HYPERNATREMIA (Orange)
Header
- Serum Na+ > 145 mmol/L
- Always = hyperosmolality
- Mortality 40-60% in critically ill patients
Primary Defect
Free water deficit relative to sodium. Brain cells lose water to ECF → neuronal shrinkage → intracranial hemorrhage (tearing of bridging veins in acute severe cases).
In chronic hypernatremia: brain cells generate idiogenic osmoles (taurine, myoinositol) to protect against dehydration - this is why rapid correction causes cerebral edema.
Causes by Volume Status
Hypovolemic Hypernatremia (most common):
- Renal water loss + inadequate replacement:
- Osmotic diuresis: DKA, HHS, mannitol, high-protein tube feeds
- Loop diuretics
- Extrarenal loss:
- Diarrhea, vomiting
- Burns
- Fever, sweating
- Respiratory (tachypnea, mechanical ventilation)
- Urine osmolality >800 mOsm/kg (kidneys concentrating urine appropriately)
Euvolemic Hypernatremia (pure water loss):
- Central Diabetes Insipidus - lack of ADH secretion:
- Trauma, surgery, pituitary tumors, granulomas (sarcoidosis), ischemia, idiopathic
- Urine osmolality <800 (often <300), urine specific gravity <1.005
- Responds to DDAVP (desmopressin)
- Nephrogenic Diabetes Insipidus - kidney resistant to ADH:
- Lithium (most common drug cause), demeclocycline, amphotericin B
- Hypercalcemia, hypokalemia (impair concentrating ability)
- CKD, sickle cell, amyloidosis
- Does NOT respond to DDAVP
- Urine osmolality low despite high plasma osmolality
- Insensible losses: fever, burns, hyperventilation
Hypervolemic Hypernatremia (sodium gain):
- Hypertonic saline administration
- Sodium bicarbonate IV (cardiac arrest resuscitation)
- Hyperaldosteronism (Conn's syndrome)
- Cushing syndrome
- Salt poisoning (rare)
- Mineralocorticoid excess
Distinguishing Central vs Nephrogenic DI (Water Deprivation Test):
| Test | Central DI | Nephrogenic DI |
|---|
| Urine osmolality after water deprivation | <300 mOsm/kg | <300 mOsm/kg |
| After DDAVP administration | Rises >50% (responds) | No significant rise (<10%) |
| Plasma ADH | Low/undetectable | High (ADH present but no effect) |
Clinical Features
| Na+ Level | Symptoms |
|---|
| 145-150 | Often asymptomatic (if chronic) |
| 150-160 | Thirst, irritability, restlessness, lethargy |
| 160-170 | Tremors, ataxia, confusion, muscle twitching |
| >170 | Coma, focal deficits, death |
| >175 (chronic) | May be asymptomatic (brain has adapted) |
Acute (Na+ >160): brain can shrink, tearing bridging veins → subdural/subarachnoid hemorrhage
Children and the elderly are at highest risk.
ECG Changes
- No specific ECG pattern
- Underlying hypervolemia may show signs of the primary condition
Treatment
Step 1 - Calculate free water deficit:
Free water deficit (L) = 0.6 × weight (kg) × [(serum Na / 140) - 1]
Step 2 - Choose replacement fluid:
- Oral water/NG free water (preferred if conscious)
- IV 5% Dextrose (D5W) - free water equivalent
- IV 0.45% NaCl (half-normal saline) - for hypovolemic patients after volume restored
- IV 0.9% NaCl (normal saline) - FIRST if hemodynamically unstable (to restore volume before correcting Na+)
Step 3 - Correction rate:
- Maximum 0.5 mmol/L/hour or 10-12 mmol/L per 24 hours
- Overcorrection → cerebral edema (brain's accumulated osmoles draw in too much water)
Specific treatments:
- Central DI: DDAVP (desmopressin) intranasal/SC/IV + free water
- Nephrogenic DI: Remove causative drug; thiazide diuretics (paradoxically reduce urine output via volume contraction); NSAIDs; low-salt, low-protein diet
- Hypervolemic: loop diuretics + 5% dextrose
COLUMN 3 - HYPOKALEMIA (Green)
Header
- Serum K+ < 3.5 mmol/L
- Normal: 3.5-5.0 mmol/L
- Most of body's K+ is intracellular (98%) - only 2% is extracellular
Primary Defect
Resting membrane potential = -90 mV (maintained by K+ gradient). Hypokalemia hyperpolarizes cells → harder to depolarize → skeletal muscle weakness, but also lowers threshold for spontaneous cardiac depolarization → arrhythmias.
Causes
A. Redistribution INTO cells (no total body deficit, serum K+ drops):
- Insulin (activates Na+/K+-ATPase) - most common in DKA treatment
- Alkalosis (H+ exits cells, K+ enters to maintain electroneutrality)
- Beta-2 agonists (salbutamol, terbutaline, adrenaline) - activate Na+/K+-ATPase
- Catecholamine excess (stress, phaeochromocytoma)
- Hypokalemic periodic paralysis (familial - attack triggered by carbs/exercise/cold)
- Vitamin B12/folate treatment (rapid cell proliferation uses K+)
- Hypothermia, theophylline toxicity
B. Decreased intake:
- Starvation, anorexia nervosa
- Total parenteral nutrition without adequate K+
- Tea-and-toast diet in elderly
C. Renal losses (24-hr urine K+ >25 mmol/day):
- Diuretics - most common drug cause:
- Loop diuretics (furosemide, bumetanide)
- Thiazides (hydrochlorothiazide, chlorthalidone)
- Mineralocorticoid excess - aldosterone increases K+ excretion:
- Primary hyperaldosteronism (Conn's syndrome) - hypertension + hypokalemia
- Secondary hyperaldosteronism (CHF, cirrhosis, renovascular HT)
- Cushing's syndrome / exogenous glucocorticoids
- Congenital adrenal hyperplasia (11β-hydroxylase, 17α-hydroxylase deficiency)
- Apparent mineralocorticoid excess, Liddle syndrome
- Bartter syndrome (autosomal recessive): loop-like salt wasting; normo/hypotension, metabolic alkalosis, very high renin/aldosterone
- Gitelman syndrome: thiazide-like; milder, hypomagnesemia, hypocalciuria; most common inherited renal tubular disorder
- Renal tubular acidosis type 1 (distal) and type 2 (proximal)
- Hypomagnesemia (blocks ROMK channel; K+ leaks out of tubular cells)
- Drugs: aminoglycosides, amphotericin B, cisplatin, penicillins (non-reabsorbable anion effect), capreomycin
D. GI losses (24-hr urine K+ <25 mmol/day - kidneys conserving K+):
- Diarrhea (K+-rich stool fluid - especially secretory diarrhea)
- Laxative abuse
- Vomiting/NG suction (K+ loss + metabolic alkalosis drives renal K+ loss secondarily)
- Enterocutaneous fistulas, ileostomy
- Villous adenoma of rectum (secretes K+-rich mucus)
Clinical Features
| System | Mild (3.0-3.5) | Moderate (2.5-3.0) | Severe (<2.5) |
|---|
| Muscle | Fatigue, cramps | Proximal weakness | Paralysis, rhabdomyolysis |
| Heart | Occasional PVCs | ECG changes, AF | VT, VF, cardiac arrest |
| GI | Constipation | Paralytic ileus | Abdominal distension |
| Kidney | Polyuria | Polydipsia | Hypokalemic nephropathy |
| Metabolic | Mild alkalosis | Glucose intolerance | Growth retardation (children) |
ECG Changes in Hypokalemia (Sequence)
| Finding | Mechanism | When |
|---|
| Flattened/inverted T waves | Delayed repolarization | K+ <3.5 |
| Prominent U wave (>T wave amplitude) | Delayed M-cell repolarization - HALLMARK | K+ <3.0 |
| ST-segment depression | - | K+ <3.0 |
| Prolonged QU interval | (not true QT prolongation) | K+ <2.5 |
| Increased P-wave amplitude, prolonged PR | - | K+ <2.5 |
| VT (torsades de pointes) / VF | Complete conduction breakdown | K+ <2.0 |
U wave: positive deflection after T wave, best seen in V2-V3. Normal U waves are small; in hypokalemia they become prominent and can exceed T wave height.
Treatment
| Severity | K+ Level | Route | Dose |
|---|
| Mild | 3.0-3.5 | Oral KCl | 40-60 mmol/day divided doses |
| Moderate | 2.5-3.0 | Oral KCl aggressive | 60-80 mmol/day; consider IV |
| Severe/Symptomatic | <2.5 or arrhythmia | IV KCl | 10-20 mmol/hr (central line preferred); max 40 mmol/hr in extreme emergency |
Key rules:
- NEVER give IV K+ as a bolus (can cause cardiac arrest)
- Max peripheral IV: 10 mmol/hr (concentrated K+ causes vein sclerosis)
- Max central IV: 20-40 mmol/hr with continuous cardiac monitoring
- Always replace magnesium first - hypomagnesemia causes refractory hypokalemia (Mg2+ is required to keep K+ inside cells via ROMK channel inhibition)
- For diuretic-induced: switch to K+-sparing diuretic (spironolactone, amiloride) or add K+ supplement
COLUMN 4 - HYPERKALEMIA (Red)
Header
- Serum K+ > 5.0 mmol/L
- Mild: 5.0-5.9 | Moderate: 6.0-6.4 | Severe: ≥6.5
- Life-threatening at >6.5, usually fatal >10.0 mmol/L
Primary Defect
High extracellular K+ partially depolarizes resting membrane potential (less negative). This inactivates Na+ channels → decreased excitability of muscle and nerve cells. In the heart, reduced resting potential = impaired conduction → bradycardia → heart block → VF.
Causes
A. Pseudohyperkalemia (K+ elevated in sample but not in the patient):
- Hemolysis during blood draw (most common) - red cells release K+
- Prolonged tourniquet time or fist-clenching
- Severe leukocytosis (WBC >70,000/mm³) - WBCs release K+ after sample drawn
- Thrombocytosis (platelets >500-1000 × 10⁹/L) - ~1/3 of these patients have pseudohyperkalemia
- Diagnosis: serum K+ >0.3 mmol/L higher than simultaneous plasma K+
- Management: repeat with plasma sample (heparin tube instead of serum tube), free-flowing sample without tourniquet
B. Redistribution OUT of cells:
- Acidosis (H+ enters cells, K+ exits to maintain electroneutrality) - metabolic or respiratory
- Insulin deficiency (normal insulin drives K+ into cells via Na+/K+-ATPase)
- Hyperosmolality (hyperglycemia, mannitol - osmotic water shift out of cells carries K+ with it)
- DKA: insulin deficiency + hyperosmolality → hyperkalemia despite total body K+ deficit
- Beta-blockers (especially non-selective: propranolol) - block beta-2 mediated cellular K+ uptake
- Digoxin toxicity (inhibits Na+/K+-ATPase)
- Succinylcholine (depolarizing NMJ blockade - causes K+ efflux; avoid in burns, denervation, rhabdomyolysis - can cause K+ rise of 0.5-1.0 mmol/L, but up to 5-10 in at-risk patients)
- Hyperkalemic periodic paralysis (hereditary Na+ channel mutation)
- Rhabdomyolysis, tumor lysis syndrome, massive hemolysis, crush injury
C. Increased K+ intake (usually only with co-existing impaired excretion):
- K+ supplements, K+-containing salt substitutes
- High-K+ foods (bananas, oranges, tomatoes, potatoes, beans) in CKD patients
- Blood transfusions (stored blood has high K+ due to hemolysis)
- Enteral/parenteral nutrition
D. Decreased renal K+ excretion (most common cause of chronic hyperkalemia):
- Acute Kidney Injury (AKI) - especially oliguric
- Chronic Kidney Disease (CKD) - GFR <10-20 mL/min
- Obstructive uropathy - bilateral obstruction
- Adrenal insufficiency (Addison's disease) - lack of aldosterone:
- Classic triad: hyperkalemia + hyponatremia + metabolic acidosis
- Check morning cortisol and ACTH stimulation test
- Hyporeninaemic hypoaldosteronism (Type IV RTA) - most common in diabetic nephropathy; low renin → low aldosterone
- Drugs reducing renal K+ excretion (most important clinically):
| Drug Class | Examples | Mechanism |
|---|
| ACE inhibitors | Enalapril, ramipril, lisinopril | Decrease angiotensin II → decrease aldosterone |
| ARBs | Losartan, valsartan, candesartan | Block AT1 receptor → decrease aldosterone |
| K+-sparing diuretics | Spironolactone, eplerenone | Block aldosterone receptor |
| K+-sparing diuretics | Amiloride, triamterene | Block ENaC directly |
| NSAIDs | Ibuprofen, naproxen | Decrease prostaglandins → decrease renin |
| Heparin (unfractionated + LMWH) | - | Direct adrenal cytotoxicity → decrease aldosterone |
| Trimethoprim | - | Blocks ENaC (amiloride-like effect) |
| Calcineurin inhibitors | Tacrolimus, cyclosporine | Decrease aldosterone effect |
- Pseudohypoaldosteronism type 2 (Gordon syndrome): hypertension + hyperkalemia + normal GFR; WNK kinase mutation → excess NaCl and K+ retention
ECG Changes in Hyperkalemia
| K+ (mmol/L) | ECG Change | Significance |
|---|
| 4-5 | Normal | - |
| 5.5-6.5 | Peaked (tented) T waves | First sign; narrow base, high amplitude; best in V2-V5 |
| 6.5-7.5 | Flattened/absent P waves, prolonged PR | Atrial standstill |
| 7-8 | Widened QRS (>0.12 sec), ST depression | Ventricular conduction delay |
| >8-9 | Sine wave pattern (QRS merges with T) | Pre-terminal rhythm |
| >9-10 | Ventricular fibrillation / asystole | Cardiac arrest |
Important: ECG changes can appear at any K+ level - a patient with K+ of 6.2 may have a sine wave pattern while another with K+ of 7.0 may have only peaked T waves. Always treat the ECG, not just the number.
Treatment - The Three-Step Approach
STEP 1 - STABILIZE the heart membrane (if ECG changes or K+ >6.5):
| Drug | Dose | Onset | Duration | Mechanism |
|---|
| IV Calcium gluconate 10% | 10 mL IV over 2-3 min | 1-3 min | 30-60 min | Raises cardiac resting membrane potential threshold; does NOT lower K+ |
| IV Calcium chloride 10% | 5-10 mL IV | 1-3 min | 30-60 min | More elemental Ca2+; preferred in cardiac arrest |
- Repeat every 5-10 min if ECG changes persist
- Do NOT mix calcium with NaHCO3 (precipitates as CaCO3)
- Give slowly over 20-30 min in digoxin toxicity (hypercalcemia worsens digoxin toxicity)
STEP 2 - SHIFT K+ into cells (temporizing - does not remove K+):
| Drug | Dose | Onset | Duration | Notes |
|---|
| Insulin 10 units IV + 50 mL of 50% dextrose | IV bolus | 15-30 min | 4-6 hr | Monitor glucose; most reliable agent |
| Salbutamol (albuterol) nebulized | 10-20 mg (high dose) | 30-60 min | 2-4 hr | Synergistic with insulin; tachycardia |
| NaHCO3 50 mmol IV | 50 mL of 8.4% | 15-30 min | 1-2 hr | Only if pH <7.2; AVOID in anuric patients (can worsen K+) |
STEP 3 - REMOVE K+ from the body (definitive):
| Method | Dose | Time to Effect | Notes |
|---|
| Furosemide IV | 40-80 mg IV | 30-60 min | Only if adequate renal function and not oliguric |
| Sodium polystyrene sulfonate (Kayexalate) | 15-60 g orally | 4-6 hr | Exchanges Na+ for K+ in colon; given with sorbitol (avoid in post-op bowel) |
| Patiromer | 8.4-25.2 g/day oral | 4-7 hr | Better tolerated; preferred for chronic management |
| Sodium zirconium cyclosilicate (SZC, Lokelma) | 10 g TID × 48h, then 5 g/day | 1-2 hr | Fastest acting resin; useful in acute setting |
| Hemodialysis | - | Minutes | Most rapid and reliable removal; used in AKI, CKD, or refractory/severe hyperkalemia |
Chronic Management
- Low-K+ diet (<2 g/day in severe cases)
- Optimize acid-base balance (correct metabolic acidosis with NaHCO3)
- Increase renal excretion: loop diuretic (furosemide), fludrocortisone (if adrenal insufficiency)
- Long-term potassium binders: patiromer or SZC
- Review all K+-raising medications - weigh benefit vs. risk (ACEi/ARB in heart failure have mortality benefit)
MASTER COMPARISON TABLE
| Feature | Hyponatremia | Hypernatremia | Hypokalemia | Hyperkalemia |
|---|
| Value | Na+ <135 | Na+ >145 | K+ <3.5 | K+ >5.0 |
| Cell Effect | Cells swell (water in) | Cells shrink (water out) | Hyperpolarized | Partially depolarized |
| CNS Effect | Cerebral edema | Cerebral dehydration | Muscle weakness | Weakness, confusion |
| ECG Hallmark | None | None | U wave, flat T | Peaked T waves → sine wave |
| Most Common Cause | SIADH, diuretics | Diabetes insipidus | Diuretics, diarrhea | AKI/CKD, ACEi/ARBs |
| Emergency Rx | 3% NaCl 100 mL bolus | D5W / 0.45% NaCl | IV KCl 20 mmol/hr | IV Calcium gluconate 10 mL |
| Second-line Rx | Treat cause, vaptans | DDAVP (central DI) | Mg2+ replacement | Insulin+Dextrose, Salbutamol |
| Definitive Rx | Fluid restriction (SIADH) | Free water replacement | Oral KCl + treat cause | Dialysis / K+ binders |
| Overcorrection Danger | ODS (demyelination) | Cerebral edema | Hyperkalemia | Hypokalemia |
| Correction Rate | Max 6-8 mmol/L per 24h | Max 0.5 mmol/L per hour | Based on severity/ECG | Based on ECG changes |
| Key Mnemonic | SIADH: Euvolemic, High Urine Na | DI: Polyuria + Hypernatremia | "Hypo K = U wave" | "Hyper K = Peaked T → Sine Wave → VF" |
This is the complete breakdown of every element in the poster. Let me know if you want a deeper dive into any specific disorder, a separate ECG-only diagram, or a flowchart for management steps.